1. "David Solit"
  2. "Melanoma and Immunotherapeutics Service"
Formats
  1. Journal Article (27)
  2. Meeting Abstract (19)
  3. Research Letter (2)
Groups
  1. Department of Medicine (48)
  2. GSK Faculty (48)
  3. Genitourinary Oncology Service (48)
  4. Human Oncology and Pathogenesis Program (48)
  5. Melanoma and Immunotherapeutics Service (48)
  6. Solid Tumor Oncology Division (48)

More Groups

People
  1. David Solit (48)
  2. Paul Chapman (24)
  3. Neal Rosen (21)
  4. Michael Berger (19)
  5. Nikolaus Schultz (16)
  6. Barry Taylor (14)

More People

Years
  1. 2023 (2)
  2. 2022 (3)
  3. 2021 (4)
  4. 2020 (3)
  5. 2019 (6)
  6. 2018 (5)

More Years

Publications
  1. Cancer Research (10)
  2. Journal of Clinical Oncology (10)
  3. Clinical Cancer Research (7)
  4. Nature (3)
  5. Annals of Oncology (2)
  6. Cancer Cell (2)

More Publications

Publishers
  1. American Association for Cancer Research (18)
  2. American Society of Clinical Oncology (12)
  3. Nature Publishing Group (7)
  4. Cell Press (3)
  5. Oxford University Press (3)
  6. American Medical Association (1)

More Publishers

Results (48)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Determinants of survival with combined HER2 and PD-1 blockade in metastatic esophagogastric cancer
    Journal Article

    Maron, S. B.; Chatila, W.; Walch, H.; Chou, J. F.; Ceglia, N.; Ptashkin, R.; Do, R. K. G.; Paroder, V.; Pandit-Taskar, N.; Lewis, J. S.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Characterizing the immune phenotype of FGFR3 mutated upper tract urothelial carcinoma (UTUC) using single-cell (sc)RNA-sequencing (seq)
    Meeting Abstract

    Katims, A. B.; Kuo, F.; Reisz, P.; Tracey, A.; Thomas, J.; Yip, W.; Merghoub, T.; Bochner, B. H.; Pietzak, E. J.; Solit, D. B.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Upper tract urothelial carcinoma transcriptome profiling and immune microenvironment characterization
    Meeting Abstract

    Yip, W.; Kim, K.; Kuo, F.; Lenis, A. T.; Chen, J. F.; Hu, W.; Clinton, T. N.; Chu, C. E.; Almassi, N.; Tracey, A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Anatomic position determines oncogenic specificity in melanoma
    Journal Article

    Weiss, J. M.; Hunter, M. V.; Cruz, N. M.; Baggiolini, A.; Tagore, M.; Ma, Y.; Misale, S.; Marasco, M.; Simon-Vermot, T.; Campbell, N. R.; more...
    Nature (2022)

    Fulltext@MSK | Save
  • Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients
    Journal Article

    Nguyen, B.; Fong, C.; Luthra, A.; Smith, S. A.; DiNatale, R. G.; Nandakumar, S.; Walch, H.; Chatila, W. K.; Madupuri, R.; Kundra, R.; more...
    Cell (2022)

    Fulltext@MSK | Save
  • Early predictors of benefit to dual anti-PD1/HER2 inhibition: Biomarker analysis from phase 2 trial of pembrolizumab/trastuzumab in HER2-positive metastatic esophagogastric (mEG) cancer
    Meeting Abstract

    Maron, S. B.; Chatila, W. K.; Walch, H. S.; Ptashkin, R.; Sabwa, S.; Ling, L.; Nagy, R.; Simmons, M.; Do, R. K. G.; Paroder, V.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Therapeutic implications of detecting MAPK-activating alterations in cutaneous and unknown primary melanomas
    Journal Article

    Shoushtari, A. N.; Chatila, W. K.; Arora, A.; Sanchez-Vega, F.; Kantheti, H. S.; Rojas Zamalloa, J. A.; Krieger, P.; Callahan, M. K.; Betof Warner, A.; Postow, M. A.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • The genetic evolution of treatment-resistant cutaneous, acral, and uveal melanomas
    Journal Article

    Makohon-Moore, A. P.; Lipson, E. J.; Hooper, J. E.; Zucker, A.; Hong, J.; Bielski, C. M.; Hayashi, A.; Tokheim, C.; Baez, P.; Kappagantula, R.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • The association between tumor mutational burden and prognosis is dependent on treatment context
    Research Letter

    Valero, C.; Lee, M.; Hoen, D.; Wang, J.; Nadeem, Z.; Patel, N.; Postow, M. A.; Shoushtari, A. N.; Plitas, G.; Balachandran, V. P.; more...
    Nature Genetics (2021)

    Fulltext@MSK | Save
  • Pembrolizumab with trastuzumab and chemotherapy (PTC) in HER2-positive metastatic esophagogastric cancer (mEG): Plasma and tumor-based biomarker analysis
    Meeting Abstract

    Maron, S. B.; Chatila, W. K.; Millang, B. M.; Sabwa, S.; Chou, J. F.; Ling, L.; Nagy, R.; Simmons, M.; Do, R. K. G.; Paroder, V.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save